Analysts expect REGENXBIO Inc. to report revenue of 14.88 M for Q3 26, against a range of 13.97 M to 15.79 M. The most recent reported quarter, Q2 26, came in at 108.02 M, a 18.8% beat against the 90.90 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 24.20 M | 21.21 M | 89.01 M | 21.36 M | 29.73 M | 30.34 M | 6.39 M | 108.02 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 24.08 M | 26.21 M | 120.59 M | 45.07 M | 26.02 M | 44.08 M | 29.52 M | 98.87 M | 15.79 M | 36.05 M | 14.77 M | 19.32 M | 17.55 M | 41.05 M | 67.93 M | 160.34 M | ||||||||||
| Low Estimate | 21.62 M | 22.19 M | 109.27 M | 37.57 M | 22.17 M | 40.77 M | 24.39 M | 82.93 M | 13.97 M | 30.65 M | 13.31 M | 16.58 M | 14.59 M | 37.42 M | 60.10 M | 135.49 M | ||||||||||
| Consensus Estimate | 22.85 M | 24.20 M | 114.93 M | 41.32 M | 24.09 M | 42.43 M | 26.96 M | 90.90 M | 14.88 M | 33.35 M | 14.04 M | 17.95 M | 16.07 M | 39.23 M | 64.02 M | 147.92 M |
Analysts expect REGENXBIO Inc. to report earnings per share of -1.28 for Q3 26, against a range of -1.39 to -1.17. The most recent reported quarter, Q2 26, came in at 0.43, a 514.3% beat against the 0.07 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.17 | -1.01 | 0.12 | -1.38 | -1.20 | -1.30 | -1.72 | 0.43 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.01 | -1.02 | 0.53 | -0.90 | -1.25 | -0.88 | -1.30 | 0.08 | -1.17 | -0.90 | -1.13 | -1.00 | -1.36 | -0.96 | -0.46 | -0.25 | ||||||||||
| Low Estimate | -1.17 | -1.12 | 0.45 | -1.04 | -1.37 | -0.94 | -1.44 | 0.06 | -1.39 | -0.98 | -1.25 | -1.12 | -1.62 | -1.12 | -0.52 | -0.27 | ||||||||||
| Consensus Estimate | -1.09 | -1.07 | 0.49 | -0.97 | -1.31 | -0.91 | -1.37 | 0.07 | -1.28 | -0.94 | -1.19 | -1.06 | -1.49 | -1.04 | -0.49 | -0.26 |
Pull Wall Street consensus for REGENXBIO Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RGNX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RGNX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RGNX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();